Sensill
Sensill is developing innovative, rapid, non-invasive diagnostic technology to identify and quantify infections caused by bacteria and fungi. Their platform analyzes volatile organic compounds emitted by microorganisms to provide real-time, accurate, and inexpensive diagnosis at the point of care, aiming to improve treatment outcomes, reduce healthcare costs, and combat antibiotic resistance.
Industries
Nr. of Employees
small (1-50)
Products
Point-of-care VOC diagnostic system for urine (UTI) — reader plus consumable
A diagnostic reader and single-use consumable workflow intended to analyze urine VOCs at the point of care and provide results in minutes; company materials state validated performance for the urine solution and an intended clinical accuracy metric.
Point-of-care VOC diagnostic system for skin and wound infections — reader plus consumable
A diagnostic reader and single-use consumable workflow intended to analyze skin and wound VOCs at the point of care and provide results in minutes; company materials state validated performance for the skin/wound solution and an intended clinical accuracy metric.
Point-of-care VOC diagnostic system for urine (UTI) — reader plus consumable
A diagnostic reader and single-use consumable workflow intended to analyze urine VOCs at the point of care and provide results in minutes; company materials state validated performance for the urine solution and an intended clinical accuracy metric.
Point-of-care VOC diagnostic system for skin and wound infections — reader plus consumable
A diagnostic reader and single-use consumable workflow intended to analyze skin and wound VOCs at the point of care and provide results in minutes; company materials state validated performance for the skin/wound solution and an intended clinical accuracy metric.
Services
Development of VOC-based diagnostic platform
Research and development of a point-of-care diagnostic platform that detects and quantifies microbial VOCs using sensor arrays, nano-optics, and AI analysis.
Development of VOC-based diagnostic platform
Research and development of a point-of-care diagnostic platform that detects and quantifies microbial VOCs using sensor arrays, nano-optics, and AI analysis.
Expertise Areas
- Point-of-care infectious disease diagnostics
- VOC-based microbial detection
- AI-driven diagnostic interpretation
- Sensor array development and nano-optics
Key Technologies
- Volatile organic compound (VOC) analysis
- Colorimetric sensor arrays (CSA)
- Nano-optical readout
- AI / machine learning for sensor interpretation